These results suggest that the beneficial consequences of liraglutide on hepatocellular steatosis and gluconeogenesis, as well as inflammation, were at least partially dependent on liraglutide-mediated upregulation of the ACE2/Ang1-7/Mas axis and downregulation of the ACE/AngII/AT1R axis. This evidence concerns the gene AGT and steatosis.